Xiaomei Zhai
Biographic Data
| ID | 6514951 |
|---|---|
| NAME | Xiaomei Zhai |
| GIVEN NAMES | Xiaomei |
| FAMILY NAME | Zhai |
| SIGNATURE | ZHAI X |
| AFFILIATIONS | Chinese Academy of Medical Sciences & Peking Union Medical College |
| ORCID | 0000-0003-0416-3977 |
| VERIFIED | Yes |
| TOTAL WORKS | 13 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 13 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Ethical reflection of Chinese scientists on the dual-use concerns of emerging medical biotechnology
Emerging medical biotechnology typically exhibits a ‘dual-use’ nature, which, while promoting human well-being, concurrently presents potential risks of misuse or abuse, thereby posing significant threats. Globally, including in China, emerging medical biotechnology is developing rapidly. To understand the views and perspectives of Chinese scientists on dual-use concerns, this empirical study conducted semistructured qualitative interviews with r…
Balancing public health and individual autonomy: A study of China’s vaccination policy
The article examines China’s vaccination policy, focusing particularly on childhood immunisation and pandemic vaccines. Although China’s laws require individuals to engage in the vaccination decision-making process, the policy does not enforce mandatory vaccination through penalties. Instead, it emphasises informed decision-making, allowing and supporting individuals to choose whether to vaccinate or adopt other preventive measures based on their…
Ethical analysis of informed consent methods in longitudinal cohort studies: A Chinese perspective
In longitudinal cohort studies involving large populations over extended periods, informed consent entails numerous urgent challenges. This paper explores challenges regarding informed consent in long‐term, large‐scale longitudinal cohort studies based on the longitudinal and dynamic nature of such research. It analyzes and evaluates widely recognized broad consent and dynamic consent methods, highlighting limitations concerning their ability to …
Innovative therapy in clinical practice: Ethical perspective from China
Innovative therapy, as a new paradigm of medical intervention deviating from standard routine practice, prioritizes the best interests of patients, offering alternative therapeutic pathways where standard treatments fail. In China, their application is increasing alongside advancements in medical technology. However, innovative therapy poses various ethical challenges in clinical settings, including misconceptions of being viewed as research rath…
Feasibility of implementing the elective oocyte cryopreservation in China: A case study
In China, a prominent case exists wherein a medically fit woman filed a lawsuit against a hospital for denying her request to undergo oocyte cryopreservation. She contended the hospital had infringed upon her rights. This paper focuses on medicalization and gender equality to discuss whether or not a hospital can infringe upon a woman's rights. We believe elective oocyte cryopreservation is not a medical treatment and it may lead to an overwhelmi…
Dual‐use research assessment in emerging medical biotechnology: An ethical perspective from China
Emerging medical biotechnology, with its dual‐use nature, presents both unprecedented opportunities and challenges for human society. As we benefit from technological innovation, it is crucial for Chinese academics and policymakers to effectively identify and address potential risks. However, the current framework for evaluating dual‐use research faces multiple challenges, including difficulties in identifying dual‐use issues, a lack of considera…
Unveiling the Ethics of Chinese Biobank: Insights from Consent Document Analysis
Biobanking in China has seen rapid development, placing the country as a key player globally. However, significant ethical challenges arise, particularly around donor autonomy in informed consent for collecting and using biological materials and personal data. This study examines how Chinese biobanks inform donors about their participation and the ethical content of consent documents. Using qualitative content analysis, 12 consent documents from …
Oocyte cryopreservation for non‐medical reasons: Ethical and regulatory concerns in China
Assisted reproductive technology is a complex medical intervention with many potential social sensitivities. Within this domain, oocyte cryopreservation has emerged as an important research area for preserving female fertility. Against the backdrop of the hotly debated first legal case in China of a single woman wishing to freeze her eggs, and the implementation of the ‘three‐child policy’ in China, there is an urgent need to evaluate policies an…
Should more attention be paid to polio sequela cases in China
Since “Global Polio Eradication Initiative” was launched by World Health Assembly in 1988, the incidence rate of polio has been reduced by more than 99%, and the whole world has entered a post polio era nowadays. China has been a polio free status recognized by World Health Organization for 22 years and most people believe that no more public health concerns need to be given. How is the population of polio survivors in China? What strategies of h…
Regulation concerns of supply and demand sides for aesthetic medicine from Chinese perspective
Aesthetic medicine has become a booming industry in the world. However, there are widespread social and health risks posed by aesthetic medicine, including illegal practice, and misleading information from aesthetic medicine institutes. Social media and advertisement play important roles in leading to appearance anxiety among young people nowadays. Regarding the chaotic situation in the aesthetic medical field, there is a fact that the practice o…
Eugenics and Mandatory Informed Prenatal Genetic Testing: A Unique Perspective from C hina
The application of genetic technologies in C hina, especially in the area of prenatal genetic testing, is rapidly increasing in C hina. In the wealthy regions of C hina, prenatal genetic testing is already very widely adopted. We argue that the government should actively promote prenatal genetic testing to the poor areas of the country. In fact, the government should prioritize resources first to make prenatal genetic testing a standard routine c…
No ethical divide between China and the West in human embryo research
This is a discussion of the reaction to the recent research article publication in the journal Protein & Cell by a group of scientists at Sun Yat‐sen University using the CRISPR /Cas9 technique on editing non‐viable human zygotes. Many commentators condemned the Chinese scientists for overstepping ethical boundaries long accepted in Western countries and accused China of having lax regulations on genomic research in general. We argue that not onl…
Physicians’ attitude toward the withdrawal of life-sustaining treatment: A comparison between Korea, Japan, and China
End-of-life care decision making has become a matter of serious ethical and legal concern in the three Far East Asian Countries of China, Japan, and Korea. Researchers in the three countries collaboratively conducted a comparative descriptive study with respect to physicians' perspectives concerning end-of-life care decisions. In spite of cultural similarities, each country has its own unique set of social, cultural, and political circumstances. …
No prominent works on this page.
Eugenics and Mandatory Informed Prenatal Genetic Testing: A Unique Perspective from C hina
The application of genetic technologies in C hina, especially in the area of prenatal genetic testing, is rapidly increasing in C hina. In the wealthy regions of C hina, prenatal genetic testing is already very widely adopted. We argue that the government should actively promote prenatal genetic testing to the poor areas of the country. In fact, the government should prioritize resources first to make prenatal genetic testing a standard routine c…
No ethical divide between China and the West in human embryo research
This is a discussion of the reaction to the recent research article publication in the journal Protein & Cell by a group of scientists at Sun Yat‐sen University using the CRISPR /Cas9 technique on editing non‐viable human zygotes. Many commentators condemned the Chinese scientists for overstepping ethical boundaries long accepted in Western countries and accused China of having lax regulations on genomic research in general. We argue that not onl…
Physicians’ attitude toward the withdrawal of life-sustaining treatment: A comparison between Korea, Japan, and China
End-of-life care decision making has become a matter of serious ethical and legal concern in the three Far East Asian Countries of China, Japan, and Korea. Researchers in the three countries collaboratively conducted a comparative descriptive study with respect to physicians' perspectives concerning end-of-life care decisions. In spite of cultural similarities, each country has its own unique set of social, cultural, and political circumstances. …
Should more attention be paid to polio sequela cases in China
Since “Global Polio Eradication Initiative” was launched by World Health Assembly in 1988, the incidence rate of polio has been reduced by more than 99%, and the whole world has entered a post polio era nowadays. China has been a polio free status recognized by World Health Organization for 22 years and most people believe that no more public health concerns need to be given. How is the population of polio survivors in China? What strategies of h…
Regulation concerns of supply and demand sides for aesthetic medicine from Chinese perspective
Aesthetic medicine has become a booming industry in the world. However, there are widespread social and health risks posed by aesthetic medicine, including illegal practice, and misleading information from aesthetic medicine institutes. Social media and advertisement play important roles in leading to appearance anxiety among young people nowadays. Regarding the chaotic situation in the aesthetic medical field, there is a fact that the practice o…
Oocyte cryopreservation for non‐medical reasons: Ethical and regulatory concerns in China
Assisted reproductive technology is a complex medical intervention with many potential social sensitivities. Within this domain, oocyte cryopreservation has emerged as an important research area for preserving female fertility. Against the backdrop of the hotly debated first legal case in China of a single woman wishing to freeze her eggs, and the implementation of the ‘three‐child policy’ in China, there is an urgent need to evaluate policies an…
Ethical reflection of Chinese scientists on the dual-use concerns of emerging medical biotechnology
Emerging medical biotechnology typically exhibits a ‘dual-use’ nature, which, while promoting human well-being, concurrently presents potential risks of misuse or abuse, thereby posing significant threats. Globally, including in China, emerging medical biotechnology is developing rapidly. To understand the views and perspectives of Chinese scientists on dual-use concerns, this empirical study conducted semistructured qualitative interviews with r…
Balancing public health and individual autonomy: A study of China’s vaccination policy
The article examines China’s vaccination policy, focusing particularly on childhood immunisation and pandemic vaccines. Although China’s laws require individuals to engage in the vaccination decision-making process, the policy does not enforce mandatory vaccination through penalties. Instead, it emphasises informed decision-making, allowing and supporting individuals to choose whether to vaccinate or adopt other preventive measures based on their…
Ethical analysis of informed consent methods in longitudinal cohort studies: A Chinese perspective
In longitudinal cohort studies involving large populations over extended periods, informed consent entails numerous urgent challenges. This paper explores challenges regarding informed consent in long‐term, large‐scale longitudinal cohort studies based on the longitudinal and dynamic nature of such research. It analyzes and evaluates widely recognized broad consent and dynamic consent methods, highlighting limitations concerning their ability to …
Innovative therapy in clinical practice: Ethical perspective from China
Innovative therapy, as a new paradigm of medical intervention deviating from standard routine practice, prioritizes the best interests of patients, offering alternative therapeutic pathways where standard treatments fail. In China, their application is increasing alongside advancements in medical technology. However, innovative therapy poses various ethical challenges in clinical settings, including misconceptions of being viewed as research rath…
Feasibility of implementing the elective oocyte cryopreservation in China: A case study
In China, a prominent case exists wherein a medically fit woman filed a lawsuit against a hospital for denying her request to undergo oocyte cryopreservation. She contended the hospital had infringed upon her rights. This paper focuses on medicalization and gender equality to discuss whether or not a hospital can infringe upon a woman's rights. We believe elective oocyte cryopreservation is not a medical treatment and it may lead to an overwhelmi…
Dual‐use research assessment in emerging medical biotechnology: An ethical perspective from China
Emerging medical biotechnology, with its dual‐use nature, presents both unprecedented opportunities and challenges for human society. As we benefit from technological innovation, it is crucial for Chinese academics and policymakers to effectively identify and address potential risks. However, the current framework for evaluating dual‐use research faces multiple challenges, including difficulties in identifying dual‐use issues, a lack of considera…
Unveiling the Ethics of Chinese Biobank: Insights from Consent Document Analysis
Biobanking in China has seen rapid development, placing the country as a key player globally. However, significant ethical challenges arise, particularly around donor autonomy in informed consent for collecting and using biological materials and personal data. This study examines how Chinese biobanks inform donors about their participation and the ethical content of consent documents. Using qualitative content analysis, 12 consent documents from …
China (12 works) · Law (12 works) · Political science (12 works) · Medicine (8 works) · Biomedical Ethics and Regulation (7 works) · Engineering ethics (5 works) · Biology (4 works) · Engineering (4 works) · Environmental health (4 works) · Autonomy (3 works)